Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The role of dendritic cell precursors in tumour vasculogenesis Coukos G; Benencia F; Buckanovich RJ; Conejo-Garcia JRBr J Cancer 2005[Apr]; 92 (7): 1182-7In this review, we discuss the recent identification in vivo of a population of CD11c+ cells exhibiting simultaneous expression of both endothelial and dendritic cell markers, termed vascular leukocytes (VLCs). VLCs are highly represented in human ovarian carcinomas and, depending on the milieu, can assemble into functional blood vessels or act as antigen-presenting cells. The identification of dendritic cell precursors as bipotent cells has important implications for the physiopathology and therapy of tumours. VLCs emerge as a novel therapeutic target against tumour vascularisation.|*Neovascularization, Pathologic[MESH]|CD11c Antigen[MESH]|Cell Differentiation[MESH]|Dendritic Cells/*physiology[MESH]|Humans[MESH]|Immunotherapy[MESH]|Leukocytes[MESH]|Neoplasms/*blood supply/*drug therapy/physiopathology[MESH]|Vascular Endothelial Growth Factor A/pharmacology[MESH] |